SUBSCRIBE
SUBSCRIBE
News   Drug Development

Sound Pharmaceuticals, Inc. Release: New Drug For Hearing Loss Enters Clinical Testing

June 12, 2006 | 
1 min read

SEATTLE, June 12 /PRNewswire/ -- Sound Pharmaceuticals initiates clinical testing of SPI-1005 for the prevention and treatment of noise induced hearing loss.

Clinical research Phase I
Sound Pharmaceuticals
MORE ON THIS TOPIC
Business
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
March 13, 2025
 · 
1 min read
 · 
Lori Ellis
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Autoimmune disease
Amgen’s Uplizna Deepens Response Against Myasthenia Gravis at 1 Year
March 13, 2025
 · 
1 min read
 · 
Tristan Manalac
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Infectious disease
Gilead, GSK-ViiV Move Ahead With Long-Acting HIV Options Following Early-Stage Readouts
March 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Entrance to Pfizer's office in Belgium
Breast cancer
Pfizer, Arvinas Post Mixed Late-Stage Breast Cancer Data for Closely Watched PROTAC Drug
March 11, 2025
 · 
2 min read
 · 
Tristan Manalac